focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTotally Regulatory News (TLY)

Share Price Information for Totally (TLY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.25
Bid: 7.00
Ask: 7.50
Change: -0.50 (-6.45%)
Spread: 0.50 (7.143%)
Open: 7.75
High: 7.75
Low: 7.25
Prev. Close: 7.75
TLY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Options and Warrants

11 Apr 2007 16:09

11 April 2007 Totally Plc (`'Totally'' or `'the Company'') Issue of Options and Warrants

Totally, the publisher and internet service provider, announces that it has today granted options over 2,500,000 ordinary shares and issued 11,306,015 warrants to subscribe for ordinary shares at an exercise price of 2.88 pence per share, being the average of the closing middle-market prices of an Ordinary Share on 4, 5 and 10 April 2007 (the Exercise Price").

The details of the options and warrants are as follows:

Warrants

The Company announced on 21 June 2004 that it had issued warrants over 2,351,159 Ordinary Shares at an exercise price of 5 pence per share ("the June 2004 Warrants") to each of The Zvhil-Mezbuz Rebbe, Grand Rabbi Y.A. Korff of Boston ("the Rebbe"), director of the Company, Dr Michael Sinclair, Non-executive Chairman of the Company and a third party shareholder (collectively the "Guarantors"). The 2004 Warrants were issued in recognition of the fact that the Guarantors had provided, and continue to provide, personal guarantees to Bank Hapoalim to support the Company's overdraft facility. In order that the Company can continue to rely on the personal guarantees given by the Guarantors the independent directors (which in this context excludes The Zvhill-Mezbuz Rebbe and Dr Sinclair who are interested in the warrant issue) have resolved to issue new warrants over 2,351,159 Ordinary Shares exercisable 2 years from the date of issue for a period of 10 years at the Exercise Price. The Guarantors have undertaken to surrender the 2004 Warrants.

In addition, the independent directors (which in this context excludes Mr Assor) have resolved to issue Dan Assor, Chief Executive of the Company, warrants over 3,080,633 Ordinary Shares exercisable for a period of 10 years at the Exercise Price. Mr Assor has agreed to surrender existing warrants over 638,633 Ordinary Shares exercisable at 5 pence per share.

Furthermore, the Board has agreed to issue warrants over 1,171,905 Ordinary Shares exercisable for a period of 10 years at the Exercise Price to Mr Andy Margolis, a member of the senior management team and a former director of the Company. Mr Margolis has agreed to surrender existing warrants over 871,905 Ordinary Shares exercisable at 5 pence per share.

Options

The Board has granted the following options under the Company's EMI scheme;

1. To Mr Margolis; options over 1,350,000 Ordinary Shares exercisable at the Exercise Price which vest 18 months from the date of grant. In addition, he has been granted options over 700,000 Ordinary Shares exercisable at the Exercise Price which vest on 1 January 2008 and Mr Margolis has agreed to surrender existing options, which vest on the same date, over the same number of shares at an exercisable price of 4.375 pence per share.

2. To members of the senior management team; options over 450,000 Ordinary Shares exercisable at the Exercise Price with vesting periods between December 2008 and April 2010.

At the date of this announcement, the directors hold the following;

The Rebbe; 27,014,000 Ordinary Shares

Warrants over 4,394,350 Ordinary Shares exercisable at 4.375 pence per share Warrants over 2,000,000 Ordinary Shares exercisable at 2 pence per share Warrants over 2,351,159 Ordinary Shares exercisable at 2.88 pence per share

Dr Sinclair 14,259,791 Ordinary Shares

Warrants over 1,166,666 Ordinary Shares exercisable at 5 pence per share Warrants over 2,000,000 Ordinary Shares exercisable at 2 pence per share Warrants over 2,351,159 Ordinary Shares exercisable at 2.88 pence per share

Dan Assor 3,043,103 Ordinary Shares

Warrants over 1,000,000 Ordinary Shares exercisable at 2.25 pence per share Warrants over 3,088,633 Ordinary Shares exercisable at 2.88 pence per share Options over 700,000 Ordinary Shares exercisable at 4.375 pence per share Options over 1,250,000 Ordinary Shares exercisable at 3.62 pence per share Options over 1,000,000 Ordinary Shares exercisable at 2.5 pence per share Options over 1,000,000 Ordinary Shares exercisable at 1.5 pence per share

Following the new issues of options and warrants detailed above there are currently;

Warrants outstanding over 30,719,679 Ordinary Shares (representing 27.3 per cent. of the issued share capital of the Company following the recent placing announced on 29 March 2007) which are exercisable at exercise prices ranging from 2 to 5 pence per share; and

Options outstanding over 14,034,000 Ordinary Shares (representing 12.5 per cent. of the issued share capital of the Company following the recent placing announced on 29 March 2007) exercisable at exercise prices ranging from 1.5 to 4.375 pence per share.

For further information:Totally Plc T: 020 7692 6929www.totallyplc.comDaniel Assor, Chief ExecutiveJohn East & Partners Limited T: 020 7628 2200

Simon Clements / David Worlidge

Hoodless Brennan T: 020 7538 1166Jon LevinsonConduit PR T: 020 7429 6606Ed Portman

TOTALLY PLC
Date   Source Headline
16th May 20244:49 pmRNSHolding(s) in Company
13th May 20242:15 pmRNSHolding(s) in Company
13th May 202411:30 amRNSHolding(s) in Company
7th May 20247:00 amRNSTrading Update
19th Apr 20245:15 pmRNSHolding(s) in Company
19th Apr 20243:00 pmRNSHolding(s) in Company
11th Mar 20247:00 amRNSContract win
7th Mar 20246:00 pmRNSHolding(s) in Company
5th Feb 20247:00 amRNSDirector/PDMR Shareholding
1st Feb 20243:00 pmRNSDirectorate Change
10th Jan 20247:00 amRNSContract Extension
8th Dec 20233:30 pmRNSHolding(s) in Company
6th Dec 20237:00 amRNSDirector/PDMR Shareholding
4th Dec 20235:45 pmRNSHolding(s) in Company
1st Dec 20239:33 amRNSDirector/PDMR Shareholding
1st Dec 20237:00 amRNSDirector/PDMR Shareholding
30th Nov 20237:00 amRNSDirector/PDMR Shareholding
28th Nov 20237:00 amRNSAdviser Update
28th Nov 20237:00 amRNSDirectorate Change
28th Nov 20237:00 amRNSInterim Results
22nd Nov 20237:00 amRNSNotice of Interim Results & Investor Presentation
4th Oct 20234:15 pmRNSHolding(s) in Company
11th Sep 202312:00 pmRNSExercise of options and change to TVR
1st Sep 202312:25 pmRNSResult of AGM
1st Sep 20237:00 amRNSAGM Statement
25th Jul 20237:00 amRNSHolding(s) in Company
18th Jul 20234:00 pmRNSExercise of options and change to TVR
13th Jul 20233:30 pmRNSHolding(s) in Company
12th Jul 202312:15 pmRNSHolding(s) in Company
12th Jul 20237:00 amRNSDividend Timetable and EPS - Corrections
11th Jul 20237:00 amRNSHolding(s) in Company
10th Jul 20237:00 amRNSPreliminary results
6th Jul 20237:00 amRNSNotice of Preliminary Results
5th Jul 20231:00 pmRNSExercise of options and change to TVR
22nd May 20237:00 amRNSTotally secures multiple contract extensions
16th May 202312:30 pmRNSExercise of options & change to TVR
2nd May 20237:01 amRNSTrading Update for 12 months ending 31 March 2023
2nd May 20237:00 amRNSAppointment of Nomad and Joint Corporate Broker
26th Apr 20237:00 amRNSFurther new contract win for urology services
18th Apr 20237:00 amRNSTotally to help reduce waiting lists in Wales
12th Apr 20237:00 amRNSTotally wins new contract for urology services
4th Apr 20237:00 amRNSTotally first to fully mobilise on NHS SVCC model
31st Mar 20235:00 pmRNSTotal Voting Rights
31st Mar 20237:00 amRNSDirector/PDMR Shareholding
20th Mar 20231:42 pmRNSExercise of options, PDMR shareholding & TVR
16th Mar 20231:34 pmRNSDirector/PDMR Shareholding
10th Mar 20231:49 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSHolding(s) in Company
8th Mar 20232:09 pmRNSDirector/PDMR Shareholding
2nd Mar 20239:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.